Module 9 2021

sCBMPs

Basic EU regulatory Documents • Annex I (2009/120/EC Directive) • CHMP/4108669/2006 Cell or tissues

• Subjected to substantial manipulation to alter physiology and biology OR • Not intended to be used in the same essential function(s) in the donor and recipient sCBMPs may contain or not contain genetically modified cells

Novartis Pharma AG- Business use only- not for further distribution

28